Latest Revenue Guidance News

Page 13 of 30
EBR Systems accelerated its U.S. commercial rollout of the WiSE CRT System in Q1 2026 with implant volumes more than doubling and revenue hitting US$2.4 million. The company also secured a key regulatory milestone in Australia with TGA Priority Review, yet losses deepened and cash burn intensified, raising fresh questions about its funding runway.
Ada Torres
Ada Torres
12 May 2026
Life360 surged to $143.1 million in Q1 2026 revenue, powered by 27% growth in paying subscribers and a 329% jump in advertising following the Nativo acquisition. The company raised its full-year guidance as it navigates temporary user growth headwinds.
Sophie Babbage
Sophie Babbage
12 May 2026
CSL Limited’s interim CEO Gordon Naylor reveals a downgraded FY26 outlook amid slower growth and announces substantial impairments tied to CSL Vifor assets. Leadership changes and transformation efforts aim to restore momentum.
Ada Torres
Ada Torres
11 May 2026
Schoolblazer reports a modest revenue dip to $55.4m in 1H FY26 amid supply chain and geopolitical headwinds but strengthens its balance sheet with a new $110 million credit facility and advances integration efforts targeting profitability in FY27.
Logan Eniac
Logan Eniac
8 May 2026
EVZ Limited projects full year revenue between $120 million and $125 million for FY26, alongside an EBITDA forecast of $8.5 million to $9 million, reflecting improved margins and operational efficiency.
Victor Sage
Victor Sage
7 May 2026
Me Today has raised its full-year revenue forecast to over NZD 7.4 million, driven by strong domestic sales and a new exclusive distribution deal in Southeast Asia. The nutritional supplements company also expects a 25% reduction in EBITDA loss, reflecting tighter cost control amid ongoing product innovation.
Victor Sage
Victor Sage
7 May 2026
Acusensus Limited maintains its FY26 revenue and EBITDA guidance while advancing multiple enforcement programs across the US, UK, New Zealand, and Australia, underpinned by new product developments and international growth.
Sophie Babbage
Sophie Babbage
6 May 2026
Resonance Health upgrades its FY26 underlying EBITDA guidance to $2.6 million, driven by operational efficiencies and growth in its Software-as-Medical Devices segment, despite a slight revenue timing delay.
Ada Torres
Ada Torres
5 May 2026
NRW Holdings has reaffirmed its FY26 guidance with revenue expected between $4.1 billion and $4.2 billion and underlying EBITA of $275 million to $285 million, supported by a robust $7.5 billion order book and strategic acquisitions in energy transition and digital innovation.
Victor Sage
Victor Sage
5 May 2026
Gentrack Group trims its FY26 revenue outlook amid strategic investments and signals a $20 million on-market share buyback post-H1 results.
Sophie Babbage
Sophie Babbage
5 May 2026
Ava Risk Group posted a $6.1 million Q3 sales intake and secured a $7 million strategic investment to fuel US expansion, while geopolitical tensions delay some Middle East orders.
Sophie Babbage
Sophie Babbage
1 May 2026
Alcidion Group delivered positive cashflow and strong new sales in Q3 FY26, with contract expansions in the UK and Australia. The company remains on track for a significant Electronic Patient Record contract signing in May.
Victor Sage
Victor Sage
29 Apr 2026

Browse the archive

Full archive